BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30411391)

  • 1. Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch.
    Cummings D; Cruise M; Lopez R; Roggenbuck D; Jairath V; Wang Y; Shen B; Rieder F
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1251-1259. PubMed ID: 30411391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease.
    Degenhardt F; Dirmeier A; Lopez R; Lang S; Kunst C; Roggenbuck D; Reinhold D; Szymczak S; Rogler G; Klebl F; Franke A; Rieder F
    Inflamm Bowel Dis; 2016 Nov; 22(11):2648-2657. PubMed ID: 27753692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.
    Bogdanos DP; Roggenbuck D; Reinhold D; Wex T; Pavlidis P; von Arnim U; Malfertheiner P; Forbes A; Conrad K; Laass MW
    BMC Gastroenterol; 2012 Aug; 12():102. PubMed ID: 22866900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.
    Coukos JA; Howard LA; Weinberg JM; Becker JM; Stucchi AF; Farraye FA
    Dig Dis Sci; 2012 Jun; 57(6):1544-53. PubMed ID: 22311367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term outcomes of ileal pouch after secondary diagnosis of Crohn's disease].
    Ayrizono Mde L; Meirelles LR; Leal RF; Coy CS; Fagundes JJ; Góes JR
    Arq Gastroenterol; 2008; 45(3):204-7. PubMed ID: 18852947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis.
    Melmed GY; Fleshner PR; Bardakcioglu O; Ippoliti A; Vasiliauskas EA; Papadakis KA; Dubinsky M; Landers C; Rotter JI; Targan SR
    Dis Colon Rectum; 2008 Jan; 51(1):100-8. PubMed ID: 18085333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal changes in ileal pouches after restorative proctocolectomy for ulcerative and Crohn's colitis.
    Ettorre GM; Pescatori M; Panis Y; Nemeth J; Crescenzi A; Valleur P
    Dis Colon Rectum; 2000 Dec; 43(12):1743-8. PubMed ID: 11156461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].
    Papp M; Sipeki N; Tornai T; Altorjay I; Norman GL; Shums Z; Roggenbuck D; Fechner K; Stöcker W; Antal-Szalmas P; Veres G; Lakatos PL
    J Crohns Colitis; 2015 Aug; 9(8):659-68. PubMed ID: 25968583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease.
    Michaels MA; Jendrek ST; Korf T; Nitzsche T; Teegen B; Komorowski L; Derer S; Schröder T; Baer F; Lehnert H; Büning J; Fellerman K; Sina C
    Inflamm Bowel Dis; 2015 Dec; 21(12):2864-72. PubMed ID: 26273818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure.
    Brown CJ; Maclean AR; Cohen Z; Macrae HM; O'Connor BI; McLeod RS
    Dis Colon Rectum; 2005 Aug; 48(8):1542-9. PubMed ID: 15937625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
    Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
    Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis.
    Truta B; Li DX; Mahadevan U; Fisher ER; Chen YY; Grace K; Velayos F; Terdiman JP
    Dig Dis Sci; 2014 Jan; 59(1):135-45. PubMed ID: 24091907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies.
    Pavlidis P; Komorowski L; Teegen B; Liaskos C; Koutsoumpas AL; Smyk DS; Perricone C; Mytilinaiou MG; Stocker W; Forbes A; Bogdanos DP
    Clin Chem Lab Med; 2016 Feb; 54(2):249-56. PubMed ID: 26351932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ileal Pouch Anal Anastomosis (IPAA) for colitis; development of Crohn's and Pouchitis.
    Kolbeinsson HM; Wall T; Bayat A; Luchtefeld M; Ogilvie JW
    Am J Surg; 2022 Jul; 224(1 Pt B):453-458. PubMed ID: 35086697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.
    Roggenbuck D; Reinhold D; Wex T; Goihl A; von Arnim U; Malfertheiner P; Büttner T; Porstmann T; Porstmann S; Liedvogel B; Bogdanos DP; Laass MW; Conrad K
    Clin Chim Acta; 2011 Apr; 412(9-10):718-24. PubMed ID: 21195704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IPAA in Known Preoperative Crohn's Disease: A Systematic Review.
    Lightner AL; Jia X; Zaghiyan K; Fleshner PR
    Dis Colon Rectum; 2021 Mar; 64(3):355-364. PubMed ID: 33315711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis.
    Shen B; Patel S; Lian L
    Aliment Pharmacol Ther; 2010 Apr; 31(7):745-53. PubMed ID: 20047579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA.
    Pavlidis P; Shums Z; Koutsoumpas AL; Milo J; Papp M; Umemura T; Lakatos PL; Smyk DS; Bogdanos DP; Forbes A; Norman GL
    Clin Chim Acta; 2015 Feb; 441():176-81. PubMed ID: 25512163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Bowel Function and Fate of the Ileal Pouch After Restorative Proctocolectomy in Patients With Crohn's Disease: A Systematic Review With Meta-Analysis and Metaregression.
    Pellino G; Vinci D; Signoriello G; Kontovounisios C; Canonico S; Selvaggi F; Sciaudone G
    J Crohns Colitis; 2020 Mar; 14(3):418-427. PubMed ID: 31412119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.